Lymph node ratio-based staging system outperforms the seventh AJCC system for gastric cancer validation analysis with National Taiwan University Hospital Cancer Registry

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 40, Issue 1, 2017, Pages 35-41

  Lee, Yueh Chang ^a   Yang, Po Jen ^d   Zhong, Yuxin ^e   Clancy, Thomas E ^b,c   Lin, Ming Tsan ^d   Wang, Jiping ^b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e CANCER HOSPITAL   (China)

Author keywords

AJCC; Cancer staging; Gastric cancer; Lymph node ratio; TNM

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; STOMACH CANCER; SURVIVAL TIME; TAIWAN; UNIVERSITY HOSPITAL; AGED; COMPARATIVE STUDY; LYMPH NODE; MORTALITY; PATHOLOGY; REGISTER; STOMACH NEOPLASMS; SURVIVAL RATE; VALIDATION STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; STOMACH NEOPLASMS; SURVIVAL RATE; TAIWAN; YOUNG ADULT;

EID: 84905306896     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0000000000000110     Document Type: Article

References (27)

1. Cancer. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed May 10, 2013.
2. Stomach Cancer. Available at: http://www.cancer.org/cancer/stomachcancer/detailedguide/index. Accessed May 10, 2013.
3. Lee J, Demissie K, Lu SE, et al. Cancer incidence among Korean- American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14:78-85.
4. Wang J, Dang P, Raut CP, et al. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18, 043 patients from the SEER database. Ann Surg. 2012;255:478-485.
5. Kong SH, Lee HJ, Ahn HS, et al. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58.
6. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471-1474.
7. Lee HK, Yang HK, Kim WH, et al. Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg. 2001;88:1408-1412.
8. Rodriguez Santiago JM, Munoz E, Marti M, et al. Metastatic lymph node ratio as a prognostic factor in gastric cancer. Eur J Surg Oncol. 2005;31:59-66.
9. Liu C, Lu P, Lu Y, et al. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC cancer. 2007;7:200.
10. Kunisaki C, Makino H, Akiyama H, et al. Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg. 2008;12:542-549.
11. Xu DZ, Geng QR, Long ZJ, et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326.
12. Deng J, Liang H, Wang D, et al. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010;17:1043-1051.
13. Sakcak I, Yildiz BD, Avsar FM, et al. Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer? World J Gastroenterol. 2011;17:4007-4012.
14. Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, et al. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277.
15. Seevaratnam R, Bocicariu A, Cardoso R, et al. How many lymph nodes should be assessed in patients with gastric cancer? A systematic review. Gastric Cancer. 2012;15(suppl 1): S70-S88.
16. Son T, Hyung WJ, Lee JH, et al. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer. 2012;118:4687-4693.
17. Lemmens VE, Dassen AE, van der Wurff AA, et al. Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol. 2011;37:488-496.
18. Sun Z, Zhu GL, Lu C, et al. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol. 2009;20:897-905.
19. Zhou Y, Zhang J, Cao S, et al. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309-317.
20. Wang W, Xu DZ, Li YF, et al. Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection-results of a singleinstitution study of 1343 Chinese patients. Ann Oncol. 2011; 22:2049-2056.
21. Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol. 2009;16:1868-1874.
22. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol. 2002;9:775-784.
23. Pedrazzani C, Sivins A, Ancans G, et al. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91.
24. Persiani R, Rausei S, Antonacci V, et al. Metastatic lymph node ratio: a new staging system for gastric cancer. World J Surg. 2009;33:2106-2111.
25. Marchet A, Mocellin S, Ambrosi A, et al. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165.
26. Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002; 9:27-34.
27. Kulig J, Sierzega M, Kolodziejczyk P, et al. Polish Gastric Cancer Study G. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg. 2009;96:910-918.